Cogent Biosciences, Inc. Share Price

Cogent Biosciences, Inc. Share Price

NASDAQ: COGT | Mid Cap
$32.44
+$0.20 (0.62%) Last updated on 29 Oct, 2026 | 20:39 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Cogent Biosciences, Inc. Stock Performance

Open
$32.73
Prev. Close
$32.24
Circuit Range
N/A
Day Range
$32.30 - $32.82
Year Range
$13.80 - $43.55
Volume
14,944
Average Traded
$32.64

Cogent Biosciences, Inc. Share Price Today

As of 29 October 2026, Cogent Biosciences, Inc.'s share price is $32.44. The stock opened at $32.73, compared to its previous close of $32.24. During today's trading session, Cogent Biosciences, Inc.'s share price traded between $32.30 and $32.82, with an average price of $32.56. Over the past 52 weeks, the stock has recorded a high of $43.55 and a low of $13.80. In terms of performance, Cogent Biosciences, Inc.'s share price has declined by 9.36% over the last six months and is up 98.66% on a year-on-year basis.

Cogent Biosciences, Inc. Share Price Chart

Line chart of the Cogent Biosciences, Inc. price trend over the selected period. The price rose overall, ranging from 32.28 to 32.99, ending at 32.44.
$32.30$32.82
L
Show Current Price
H

Cogent Biosciences, Inc. Stock Fundamentals & Key Indicators

Market Cap
$4.18B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.92
Revenue (TTM)
$0.00
Return On Equity (TTM)
-62.44%
Profit Margin
N/A
Debt to Equity
0.42
Quarterly Earnings Growth YoY
-28.83%

Cogent Biosciences, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$69.03-$88.42-$86.02-$88.93
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-28.09%2.71%-3.38%

Cogent Biosciences, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$101.46-$154.93-$201.42-$277.89
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-52.70%-30.01%-37.97%

About Cogent Biosciences, Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

Cogent Biosciences, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$32.01
$32.38
+0.95%
Sep 2026
$34.90
$32.08
-13.50%
Aug 2026
$38.40
$37.08
-4.70%
Jul 2026
$38.71
$38.91
+0.52%
Jun 2026
$34.90
$38.71
+10.68%
May 2026
$36.06
$34.98
-2.28%
Apr 2026
$37.66
$35.79
-7.04%
Mar 2026
$38.09
$38.50
-0.99%
Feb 2026
$36.41
$38.88
+8.22%
Jan 2026
$35.73
$35.93
+1.15%
Dec 2025
$39.43
$35.52
-11.73%
Nov 2025
$16.66
$40.24
+146.43%

COGT Share Price FAQs